These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6164906)

  • 21. Study of adjuvant and mitogenic activities of bacterial peptidoglycans with different structures.
    Guenounou M; Goguel AF; Nauciel C
    Ann Immunol (Paris); 1982; 133D(1):3-13. PubMed ID: 6818895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetically permissive recognition of adjacent epitopes from the 19-kDa antigen of Mycobacterium tuberculosis by human and murine T cells.
    Harris DP; Vordermeier HM; Friscia G; Román E; Surcel HM; Pasvol G; Moreno C; Ivanyi J
    J Immunol; 1993 Jun; 150(11):5041-50. PubMed ID: 8496604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies in the enhancement of tumour immunity by coupling strong antigens to tumour cells ('heterogenization of tumours'). Helper T cell clones against PPD help other T cells mount anti-tumour responses to PPD-coupled tumour cells.
    Sia DY; Lachmann PJ; Leung KN
    Immunology; 1984 Apr; 51(4):755-63. PubMed ID: 6200428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoptive transfer of delayed type hypersensitivity reactions specific for Leishmania major antigens to normal mice using murine T cell populations and clones generated in vitro.
    Lima GC; Engers HD; Louis JA
    Clin Exp Immunol; 1984 Jul; 57(1):130-8. PubMed ID: 6204797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local adoptive transfer of skin delayed-type hypersensitivity initiated by a single T lymphocyte.
    Marchal G; Seman M; Milon G; Truffa-Bachi P; Zilberfarb V
    J Immunol; 1982 Sep; 129(3):954-8. PubMed ID: 6980927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Radiosensitivities of sensitized lymphocytes (author's transl)].
    Taniguchi K
    Fukuoka Igaku Zasshi; 1979 Mar; 70(3):49-65. PubMed ID: 312238
    [No Abstract]   [Full Text] [Related]  

  • 27. Persistence of immunogenic pulmonary metastases in the presence of protective anti-melanoma immunity.
    Donawho CK; Pride MW; Kripke ML
    Cancer Res; 2001 Jan; 61(1):215-21. PubMed ID: 11196164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed type hypersensitivity to mycobacterial antigens without protective immunity: a failure to produce the right specificity or the right type of immune reaction?
    Løvik M; Closs O
    Scand J Infect Dis Suppl; 1980; Suppl 24():224-7. PubMed ID: 7010561
    [No Abstract]   [Full Text] [Related]  

  • 30. [Regulation of delayed type hypersensitivity by antigen specific T cell factors].
    Aihara Y; Minami M; Okuda K
    Tanpakushitsu Kakusan Koso; 1982 Aug; 27(10):1281-90. PubMed ID: 6184747
    [No Abstract]   [Full Text] [Related]  

  • 31. [Delayed hypersensitivity reaction and natural cellular immunity. A comparative study of the effectiveness of different immunomodulators].
    Gordienko SM
    Patol Fiziol Eksp Ter; 1985; (3):63-7. PubMed ID: 4041025
    [No Abstract]   [Full Text] [Related]  

  • 32. Delayed-type hypersensitivity reactions to tumor-associated antigens in colon carcinoma patients immunized with an autologous tumor cell/Bacillus Calmette-Guérin vaccine.
    Bloemena E; Gall H; Ransom JH; Pomato N; Murray JH; Bos E; Scheper RJ; Meijer CJ; Hanna MG; Vermorken JB
    Cancer Res; 1993 Feb; 53(3):456-9. PubMed ID: 7678773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
    Miller SD; Butler LD
    J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed-type hypersensitivity to sheep red blood cells in selected lines of mice with high or low antibody responses.
    Lagrange PH; Michel JC; Hurtrel B; Thickstun PM
    Ann Immunol (Paris); 1980; 131C(3):257-77. PubMed ID: 7406440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential antigen presentation in tumor immunity.
    Schatten S; Drebin JA; Granstein RD; Greene MI
    Fed Proc; 1984 Jun; 43(9):2460-4. PubMed ID: 6327399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of vesicular stomatitis virus (VSV) infection on the development and regulation of T cell-mediated immune responses.
    Sy MS; Tsurufuji M; Finberg R; Benacerraf B
    J Immunol; 1983 Jul; 131(1):30-6. PubMed ID: 6190912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local passive transfer of delayed type hypersensitivity to syngeneic testicular cells in mice.
    Sakamoto Y; Sanui H; Yoshida S; Nomoto K
    Clin Exp Immunol; 1984 May; 56(2):353-60. PubMed ID: 6203673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-cell-mediated antitumor immune response induced by oncofetal antigens.
    Gautam S; Deodhar SD
    J Natl Cancer Inst; 1981 Oct; 67(4):939-45. PubMed ID: 6974275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the mechanism of the enhancement of delayed-type hypersensitivity by pertussigen.
    Sewell WA; Munoz JJ; Scollay R; Vadas MA
    J Immunol; 1984 Oct; 133(4):1716-22. PubMed ID: 6206132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
    Toffaletti DL; Darrow TL; Scott DW
    J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.